Last updated: August 17, 2026

Stem Cells: Facilitators of Immune Evasion in Cancer

Stem cells, possessing unique self-renewal and differentiation capabilities, play a pivotal role in cancer development and progression. Their capacity to evade immune surveillance and contribute to tumor growth has garnered significant attention in recent cancer research.

Stem cells can employ various mechanisms to escape immune recognition. They express low levels of major histocompatibility complex (MHC) molecules, which are essential for antigen presentation to immune cells. Additionally, stem cells secrete immunosuppressive molecules that inhibit the activation and proliferation of immune effector cells. This immune evasion allows stem cells to persist within the tumor microenvironment and contribute to tumor growth and metastasis.

Stem Cell Plasticity: Fueling Tumor Progression and Resistance

Stem cell plasticity refers to their ability to differentiate into multiple cell types. In the context of cancer, this plasticity enables stem cells to adapt to changing tumor conditions and contribute to tumor progression and treatment resistance. Stem cells can differentiate into specialized tumor cells that exhibit increased invasiveness, metastasis, and resistance to chemotherapy and radiation therapy.

Furthermore, stem cells can undergo epithelial-mesenchymal transition (EMT), a process that allows them to acquire a more migratory and invasive phenotype. This EMT-induced plasticity facilitates tumor cell dissemination and metastasis to distant sites. By exploiting their plasticity, stem cells can evade treatment modalities and contribute to the overall aggressiveness and resistance of tumors.

In conclusion, stem cells play a multifaceted role in immune evasion and tumor progression. Their ability to escape immune surveillance and undergo phenotypic changes contributes to tumor growth, metastasis, and resistance to therapy. Understanding the mechanisms underlying stem cell-mediated immune evasion and plasticity is crucial for developing effective cancer treatments that target these elusive cells.

Scientific Evidence

Research in stem cells and cellular technologies continues to develop across regenerative medicine, immunology and tissue repair. The strength of evidence differs considerably between cell types, medical conditions and treatment protocols. Laboratory findings, early clinical studies and established therapeutic applications should therefore be evaluated separately. Any clinical decision should be based on the patient’s diagnosis, current medical status, available evidence and the regulatory framework applicable in the country of treatment.

Extracellular Vesicles and Exosomes

Extracellular vesicles, including populations commonly described as exosomes, are being investigated as mediators of intercellular communication and paracrine activity. Their biological properties depend on the source cells, isolation method, characterization, concentration and storage conditions. Measurements expressed only as particle numbers do not provide a complete assessment of identity, purity or potency. Clinical claims should therefore be distinguished carefully from laboratory research and early-stage clinical evidence.

Extracellular Vesicles and Exosomes

Extracellular vesicles, including populations commonly described as exosomes, are being investigated as mediators of intercellular communication and paracrine activity. Their biological properties depend on the source cells, isolation method, characterization, concentration and storage conditions. Measurements expressed only as particle numbers do not provide a complete assessment of identity, purity or potency. Clinical claims should therefore be distinguished carefully from laboratory research and early-stage clinical evidence.

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

Categories:   Chronic Bronchitis  StrokeStem Cell Marketstem cell therapiesStem Cell therapyStem Cell Therapy & Clinical ResearchStem Cells Clinical Trialsstem cells therapyStem cells therapy of cerebral palsystem cells treatmentstem cells treatment in ukrainestem cells warningsurgery

NBScience

contract research organization

WhatsApp